Loading...
XNAS
INMD
Market cap831mUSD
Jul 09, Last price  
15.01USD
1D
3.80%
1Q
10.94%
IPO
114.12%
Name

Inmode Ltd

Chart & Performance

D1W1MN
XNAS:INMD chart
P/E
9.20
P/S
2.33
EPS
1.63
Div Yield, %
Shrs. gr., 5y
-4.91%
Rev. gr., 5y
12.44%
Revenues
370m
-6.16%
23,082,00053,456,000100,162,000156,361,000206,107,000357,565,000454,271,000492,048,000394,818,000370,495,000
Net income
94m
-48.24%
336,0008,819,00022,371,00061,145,00075,030,000164,971,000161,520,000197,919,000181,275,00093,831,000
CFO
85m
-35.73%
2,996,00014,609,00036,886,00062,206,00079,225,000174,885,000181,578,000176,826,000132,664,00085,257,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

InMode Ltd. is a medical technology company that engineers, produces, and commercializes aesthetic medical devices globally, including within the United States. The firm's product portfolio is extensive, covering both less-invasive and non-surgical solutions. A core focus lies in their minimally invasive offerings, which leverage exclusive radiofrequency-assisted lipolysis (RFAL) and deep subdermal fractional radiofrequency technologies. These advanced devices facilitate a range of procedures, such as liposuction with concurrent skin firming, body and facial sculpting, intensive skin resurfacing treatments, and various women's health-related aesthetic interventions. Beyond these, InMode also provides non-invasive medical aesthetic products designed to address numerous cosmetic concerns. These include lasting hair removal, facial skin revitalization, the reduction of wrinkles, cellulite improvement, enhancing overall dermal quality and texture, and treating minor vascular and pigmented skin imperfections. Furthermore, the company develops automated, hands-free medical aesthetic systems for applications like dermal tightening, adipose tissue reduction, and muscular toning. Established in 2008, InMode Ltd. operates from its headquarters in Yokneam, Israel. The company was previously known as Invasix Ltd. before officially changing its name in November 2017.
IPO date
Aug 08, 2019
Employees
480
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT